维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

3篇 您的检索式：作者名="Parazzini F."

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	对卡铂-紫杉醇化疗产生完全应答的晚期卵巢癌患者的生存率及预后因素显示文摘Objective. We evaluated the characteristics and determinants of 5-year survival in ovarian cancer patients with complete response after first line treatment who entered a randomised study comparing two different chemotherapeutic schedules. Methods. This analysis included 232 ovarian cancer patients with complete response after first line surgery and chemotherapy coming from a large randomised trial comparing the effect of different doses of paclitaxel combined with fixed doses of carboplatin. Results. The 5-year overall survival in patients was 57.3%. The difference in 5-year survival for age < 52 years (65.1%), 53-62 (51.4%) and ≥63 (51.2%) was statistically significant (P = 0.048). The 5-year overall survival rates were 64.6%for stage III and 57.9%for stage IV. Serous and clear cell histotypes had a worse 5-year overall survival (51.5%and 50.8%respectively), while the endometrioid and mucinous had 67.1%and 71.4%: these differences were statistically different (P = 0.04). Women with residual tumour of 1 cm or smaller after primary surgery had better 5-year survival rates: 71.2%for patients with residual tumour ≤1 cm and 46.9%for residual tumour >1 cm: these differences were statistically significant (P < 0.006). Conclusion. This study shows that in women with ovarian cancer and complete response after first line surgery and chemotherapy, age, histotype and residual tumour after surgery are determinants of 5-year overall survival.	Polverino G. Parazzini F. Stellato G. 朱晓明	2006	世界核心医学期刊文摘(妇产科学分册)2006，0，2：	0
	2	细菌性阴道病的危险因素	Chiaffarino F. Parazzini F. De Besi P. Lavezzari M. 高雪莲	2005	世界核心医学期刊文摘(妇产科学分册)2005，0，4：	0
	3	子宫内膜异位症短期复发率的决定因素	Parazzini F. Bertulessi C. Pasini A. 张剑萍	2005	世界核心医学期刊文摘(妇产科学分册)2005，0，12：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费